Trump has doubled tariffs on Indian imports to 50 per cent, citing New Delhi’s ongoing trade ties with Russia. The move came ...

AstraZeneca Plc may sell some of its medicines directly to patients in the US, joining several other drugmakers that have plans to bypass middlemen or are considering them.

AstraZeneca has been doubling down on the U.S. market, saying in its second-quarter earnings report on Tuesday that the country was key to its ambition of delivering $80 billion in revenue by the ...

AstraZeneca Q2 Results Climb; Confirms FY25 Outlook July 29, 2025 — 02:21 am EDT Written by RTTNews.com for RTTNews -> (RTTNews) - British drug major AstraZeneca Plc.

AstraZeneca PLC (NASDAQ:AZN) is one of the Stocks With Huge Catalysts on the Horizon. On July 24, AstraZeneca PLC (NASDAQ:AZN) announced positive results for its global Phase 3 trial of ...

AstraZeneca posts higher sales driven by cancer treatment demand. Discover their impressive revenue growth and future plans.

NEW YORK – Strong uptake of AstraZeneca's Tagrisso (osimertinib) in the second quarter of 2025 and positive overall survival results from the Phase III FLAURA2 trial have bolstered the firm's ...

During Brazil's COVID-19 vaccination campaign, when several brands of vaccines were available and the Chinese vaccine was the most common, an unprecedented phenomenon occurred. People crossed ...

TEL AVIV — Two prominent Israeli rights groups on Monday said their country is committing genocide in Gaza, the first time that local Jewish-led organizations have made such accusations against ...

This Is the Most Expensive Country to Visit in 2025 With high inflation and daily costs, travelers can expect to spend more than $400 per day at this gorgeous destination.